// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

GENETIC ANALYSIS OF OVER ONE MILLION PEOPLE IDENTIFIES 535 NOVEL LOCI ASSOCIATED WITH BLOOD PRESSURE AND RISK OF CARDIOVASCULAR DISEASE

Warren, H.R - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IDENTIFICATION OF RADIAL VASCULAR WALL ABNORMALITIES BY VERY-HIGH FREQUENCY ULTRASOUND IN FIBROMUSCULAR DYSPLASIA AND SPONTANEOUS CORONARY ARTERY DISSECTION ( THE FUCHSIA STUDY )

Bruno, R.M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

CAN MEASURES OF VASCULAR COMPLIANCE BE USED TO PREDICT SARCOPENIA IN THE ELDERLY?

Kirkham, F.A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

N/A

RADIANCE-HTN SOLO ( A MULTICENTER, RANDOMIZED, SHAM-CONTROLLED STUDY OF RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION IN THE ABSENCE OF ANTIHYPERTENSIVE MEDICATIONS )

Azizi, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

SEX-SPECIFIC REGULATION OF URINARY PEPTIDES IN EARLY DIABETIC NEPHROPTHY

Currie, G - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

DAILY PHYSICAL EXERCISE FOR 15 MINUTES, IMPROVES THE CONTROL OF HYPERTENSION AND ARTERIAL STIFFNESS IN OBESE HYPERTENSIVE PATIENTS

Sole, R. Cabrera - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

SELF-MONITORING IS NOT JUST FOR A STUDY, SELF-MONITORING IS FOR LIFE ( ANALYSIS OF PATIENT LIKELIHOOD TO CONTINUE SELF-MONITORING FOLLOWING A HYPERTENSION SELF-MANAGEMENT STUDY )

Schwartz, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

PARAMETERS DERIVED FROM RESERVOIR PRESSURE ANALYSIS INDEPENDENTLY PREDICT CARDIOVASCULAR EVENTS IN A MULTI-CENTRE STUDY OF INDIVIDUALS WITH TYPE 2 DIABETES

Aizawa, K - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

IMMEDIATE, SIGNIFICANT DECLINE IN CENTRAL AND PERIPHERAL BLOOD PRESSURE WITH CENTRAL ARTERIAL VENOUS ANASTOMOSIS

Saxena, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Eurolung Risk Score is Associated with Long-Term Survival following Curative Resection for Lung Cancer

Alessandro Brunelli - American Association for Thoracic Surgery (AATS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Factors Associated with Unplanned Reinterventions and Their Relation to Early Mortality After Pediatric Cardiac Surgery - Results from a Prospective Multicenter Study

Dan Mihai Dorobantu - American Association for Thoracic Surgery (AATS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long-Term Biventricular Function and Remodeling Follow Cone Reconstruction for Ebstein's Anomaly

Ralph M.L. Neijenhuis - American Association for Thoracic Surgery (AATS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ebstein anomaly

N/A

THE EFFECT OF ENDOVASCULAR BAROREFLEX AMPLIFICATION ON SYMPATHETIC NERVE ACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION ( A PROOF-OF-MECHANISM STUDY )

van Kleef, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Hypertension

N/A

HYPERTENSION IN AORTIC STENOSIS ( RELATIONSHIP WITH REVEALED SYMPTOMS AND FUNCTIONAL MEASURES ON TREADMILL EXERCISE )

Saeed, S - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

BLOOD PRESSURE AND RISK OF VALVULAR HEART DISEASE ( A MENDELIAN RANDOMISATION STUDY )

Nazarzadeh, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac valvular dysplasia X-linked

N/A

TWENTY-FOUR-HOUR URINARY SODIUM AND POTASSIUM EXCRETION IN CHINA ( A SYSTEMATIC REVIEW AND META-ANALYSIS )

Tan, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

MASKED UNCONTROLLED HYPERTENSION IN TREATED HYPERTENSIVE PATIENTS IS NOT RELATED TO ANXIETY COMPARED TO TRUE CONTROLLED HYPERTENSION

Siddiqui, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

DOES POST-STROKE WHITE COAT HYPERTENSION/EFFECT (WCH/E) REQUIRE INTENSIVE BLOOD PRESSURE MANAGEMENT?

Nuredini, G.N - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Transient Ischemic Attack

Integra

GENETIC AND ENVIRONMENT INTERACTIONS CONTRIBUTE TO LONGEVITY ( A CASE-CONTROL STUDY WITH CENTENARIANS )

Oliveira - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Mecasermin rinfabate

EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE ( UPDATED DATA FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP OF 3 YEARS )

Ott, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

Copyright © 2026. QuantiNova All rights reserved